C57BL/6NCya-Tusc3em1flox/Cya
Common Name:
Tusc3-flox
Product ID:
S-CKO-16932
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tusc3-flox
Strain ID
CKOCMP-80286-Tusc3-B6N-VA
Gene Name
Product ID
S-CKO-16932
Gene Alias
N33
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
8
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Tusc3em1flox/Cya mice (Catalog S-CKO-16932) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000239508
NCBI RefSeq
NM_030254
Target Region
Exon 2
Size of Effective Region
~0.6 kb
Detailed Document
Overview of Gene Research
TUSC3, short for Tumor Suppressor Candidate 3, is a gene located on chromosome 8p22. It encodes a 34 kD protein which is a subunit of the oligosaccharyl transferase responsible for the N-glycosylation of nascent proteins in the endoplasmic reticulum [1]. It is also involved in magnesium transport and homeostasis as an Mg2+-transporter, which is crucial for learning and memory, embryonic development, and testis maturation [1]. Dysregulation of TUSC3 has been linked to various diseases, especially cancer, highlighting its biological importance. Genetic models, such as gene knockout models, can be valuable for studying its functions.
In cervical squamous cell carcinoma, down-regulation of TUSC3 promoted cell metastasis via the AKT signalling pathway, suggesting it may serve as a prognostic marker and potential target [2]. In hepatocellular carcinoma, decreased TUSC3 expression led to enhanced cell proliferation and migration, and it regulated epithelial-mesenchymal transition (EMT) through the LIPC/AKT axis [3]. In colorectal cancer, TUSC3 was found to promote the formation of cellular stemness and induce drug resistance via the Hedgehog signalling pathway [4]. Also, its promoter methylation in peripheral blood cells shows promise as a biomarker for CRC diagnosis [5]. In clear cell renal cell carcinoma, TUSC3 expression was downregulated, and it may inhibit the progression of the disease, potentially serving as a tumor marker for early diagnosis and prognosis [6]. In glioblastoma, epigenetic reactivation of TUSC3 can reprogram sensitivity to temozolomide regardless of MGMT promoter methylation status [7].
In conclusion, TUSC3 is essential for protein N-glycosylation and magnesium homeostasis. Through gene knockout or other loss-of-function models in various cancers, it has been revealed that TUSC3 plays significant roles in cancer cell proliferation, invasion, metastasis, drug resistance, and EMT. Understanding TUSC3 functions can provide new insights into cancer mechanisms and potential therapeutic targets. Additionally, its potential as a biomarker in cancer diagnosis and as a therapeutic target in XMEN disease further emphasizes its importance in biomedical research.
References:
1. Yu, Xinshuang, Zhai, Chunjuan, Fan, Yujun, Wang, Jia, Du, Juan. 2017. TUSC3: a novel tumour suppressor gene and its functional implications. In Journal of cellular and molecular medicine, 21, 1711-1718. doi:10.1111/jcmm.13128. https://pubmed.ncbi.nlm.nih.gov/28272772/
2. Sun, Fei, Jie, Qiuling, Li, Qi, Yue, Xiaojing, Ma, Yanlin. 2022. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway. In Journal of cellular and molecular medicine, 26, 1629-1642. doi:10.1111/jcmm.17204. https://pubmed.ncbi.nlm.nih.gov/35137520/
3. Deng, Ruxia, Lu, Xiansheng, Hong, Chang, Chen, Qiaoyu, Lin, Jie. 2022. Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis. In Journal of translational medicine, 20, 485. doi:10.1186/s12967-022-03690-3. https://pubmed.ncbi.nlm.nih.gov/36274132/
4. Ren, Yansong, Deng, Ruxia, Cai, Rui, Ding, Yanqing, Lin, Jie. . TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer. In Carcinogenesis, 41, 1755-1766. doi:10.1093/carcin/bgaa038. https://pubmed.ncbi.nlm.nih.gov/32338281/
5. Siri, Goli, Mosallaei, Meysam, Ehtesham, Naeim, Nasrollahzadeh Sabet, Mehrdad, Behroozi, Javad. 2023. TUSC3 Methylation in Peripheral Blood Cells as a Biomarker for Diagnosis of Colorectal Cancer. In Advanced biomedical research, 12, 174. doi:10.4103/abr.abr_396_22. https://pubmed.ncbi.nlm.nih.gov/37564442/
6. Yan, Youji, Chen, Zhongjun, Liao, Yixiang, Zhou, Jiajie. 2019. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma. In Oncology letters, 17, 5073-5079. doi:10.3892/ol.2019.10161. https://pubmed.ncbi.nlm.nih.gov/31186719/
7. Wu, Qiong, Berglund, Anders E, Macaulay, Robert J, Etame, Arnold B. 2023. Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status. In International journal of molecular sciences, 24, . doi:10.3390/ijms242015179. https://pubmed.ncbi.nlm.nih.gov/37894860/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen